TrialPanorama/TrialPanorama-database huggingface dataset:
Study 21992849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17470516 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 17470516 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 15894969 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15894969 — Surrogate Endpoint (SUR): Blood pressure
Study 15894969 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7783109 — Surrogate Endpoint (SUR): Blood pressure
Study 7783109 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19699854 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 15492133 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10516738 — Surrogate Endpoint (SUR): Blood pressure
Study 7854377 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2124446 — Surrogate Endpoint (SUR): Blood pressure
Study 22250038 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 17325272 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28929669 — Monitoring Biomarker (MOI): HBV DNA
Study 22539020 — Surrogate Endpoint (SUR): Blood pressure
Study 22539020 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 11259518 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 21628668 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18250489 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10365144 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 25309087 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 25309087 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 15665624 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 15665624 — Predictive Biomarker (PRD): RTL1 mRNA
Genes: RTL1; MAR1; MART1; PEG11
Study 8471126 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 28969699 — Predictive Biomarker (PRD): ATP1A3 mRNA
Genes: ATP1A3
Study 26499966 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9012642 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 9012642 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 7970216 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 2129320 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 30337697 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 27842179 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27842179 — Surrogate Endpoint (SUR): Serum potassium
Study 27842179 — Surrogate Endpoint (SUR): Blood pressure
Study 24010637 — Surrogate Endpoint (SUR): Bone mineral density
Study 16565252 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 9279532 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 3774016 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 9892032 — Surrogate Endpoint (SUR): Serum potassium
Study 9892032 — Surrogate Endpoint (SUR): Blood pressure
Study 2363736 — Safety Biomarker (SAF): Interleukin 1
Study 348096 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 26725184 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25332253 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 21823052 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 21823052 — Surrogate Endpoint (SUR): Bone mineral density
Study 31289905 — Predictive Biomarker (PRD): FGF13 mRNA
Genes: FGF13; FHF2
Study 15182773 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 27122150 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 20515440 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 18936041 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15730048 — Surrogate Endpoint (SUR): Bone mineral density
Study 12517683 — Surrogate Endpoint (SUR): Blood pressure
Study 8228208 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8228208 — Surrogate Endpoint (SUR): Blood pressure
Study 30051365 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 18828196 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 18828196 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 16077402 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16077402 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 30946523 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 17763613 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 26141683 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 10750134 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1797509 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1797509 — Surrogate Endpoint (SUR): Serum triglycerides
Study 7005630 — Surrogate Endpoint (SUR): Blood pressure
Study 11327741 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 8189403 — Surrogate Endpoint (SUR): Blood pressure
Study 17313906 — Surrogate Endpoint (SUR): Blood pressure
Study 17313906 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7977476 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30079756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 29369450 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 24484547 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17200359 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 12407485 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8527351 — Surrogate Endpoint (SUR): Blood pressure
Study 24595550 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20945151 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22945782 — Surrogate Endpoint (SUR): Serum creatinine
Study 22945782 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30049885 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 21029821 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21029821 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15996060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15996060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8942411 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23458319 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 1201769 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 1201769 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 12919154 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 12919154 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 8740084 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study 25941207 — Predictive Biomarker (PRD): CHRNA5 mRNA
Genes: CHRNA5; NACHRA5
Study 30755061 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 30755061 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 30755061 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23178050 — Surrogate Endpoint (SUR): Blood pressure
Study 22047557 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 15014543 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 29552916 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 3551011 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21730344 — Surrogate Endpoint (SUR): Blood pressure
Study 19700198 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 3764810 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 28368953 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 11187915 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 30073637 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8700340 — Surrogate Endpoint (SUR): Blood pressure
Study 31858966 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27916140 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 10882149 — Surrogate Endpoint (SUR): Bone mineral density
Study 28355359 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28355359 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 28355359 — Safety Biomarker (SAF): IL-6 and IL-10
Study 4040887 — Surrogate Endpoint (SUR): Blood pressure
Study 24418351 — Surrogate Endpoint (SUR): Blood pressure
Study 19060514 — Safety Biomarker (SAF): Hyaluronic acid
Study 15951715 — Surrogate Endpoint (SUR): Blood pressure
Study 14616321 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 8237812 — Surrogate Endpoint (SUR): Blood pressure
Study 25945213 — Predictive Biomarker (PRD): DHH mRNA
Genes: DHH
Study 21949754 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 17031284 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 17031284 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 312976 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 28134057 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 28134057 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24583364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24583364 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19483370 — Surrogate Endpoint (SUR): Blood pressure
Study 29046732 — Predictive Biomarker (PRD): ADRB3 mRNA
Genes: ADRB3; ADRB3R; B3AR
Study 29046732 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12622768 — Safety Biomarker (SAF): Human leucocyte antigen
Study 12622768 — Surrogate Endpoint (SUR): Bone mineral density
Study 28522085 — Surrogate Endpoint (SUR): Blood pressure
Study 26265075 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 23294528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10843171 — Surrogate Endpoint (SUR): Bone mineral density
Study 8869876 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8869876 — Surrogate Endpoint (SUR): Blood pressure
Study 6845106 — Surrogate Endpoint (SUR): Serum calcium
Study 22752297 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study 8845580 — Surrogate Endpoint (SUR): Blood pressure
Study 2332919 — Surrogate Endpoint (SUR): Blood pressure
Study 2332919 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2332919 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 6774359 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 6774359 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 6774359 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 28625442 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 28625442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 28625442 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 25888548 — Surrogate Endpoint (SUR): Pathological complete response
Study 23648611 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 23648611 — Safety Biomarker (SAF): BDNF
Study 14984434 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 8181318 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 3371392 — Surrogate Endpoint (SUR): Blood pressure
Study 27335139 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 27335139 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 22033512 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 6881978 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 27082736 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 27082736 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 27082736 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 19786130 — Surrogate Endpoint (SUR): Serum calcium
Study 15209391 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 2724486 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15883229 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15883229 — Surrogate Endpoint (SUR): Blood pressure
Study 15883229 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7486293 — Surrogate Endpoint (SUR): Forced vital capacity
Study 27207905 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17653005 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 15785303 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9803444 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 2551765 — Safety Biomarker (SAF): Glutamate dehydrogenase
Study 31349003 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 31349003 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 31349003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31349003 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 25514794 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 25514794 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 25514794 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 25514794 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21109771 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 21173560 — Monitoring Biomarker (MOI): HBV DNA
Study 9856379 — Surrogate Endpoint (SUR): Blood pressure
Study 27966032 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 27966032 — Predictive Biomarker (PRD): DTL mRNA
Genes: DTL; CDT2; CDW1; DCAF2; L2DTL; RAMP
Study 22093196 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 26850799 — Surrogate Endpoint (SUR): Blood pressure
Study 20377407 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 15258964 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11122141 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 9308808 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 25531109 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 25531109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25531109 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25531109 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 25531109 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 25531109 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 22158433 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22158433 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29855444 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 17986694 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 17986694 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 9663244 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 9663244 — Surrogate Endpoint (SUR): Serum calcium
Study 25361981 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25361981 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 25361981 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study 25361981 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 25361981 — Predictive Biomarker (PRD): E2F3 mRNA
Genes: E2F3; KIAA0075
Study 21828126 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 21828126 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 20487638 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 20487638 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 9798657 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24517052 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 24517052 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9709410 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 9709410 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 22805498 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22805498 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 22805498 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21061834 — Surrogate Endpoint (SUR): Blood pressure
Study 17376712 — Predictive Biomarker (PRD): MUC22 mRNA
Genes: MUC22; G4; PBMUCL1
Study 16329464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16329464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17984150 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 16416004 — Monitoring Biomarker (MOI): HBV DNA
Study 7554545 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 7554545 — Surrogate Endpoint (SUR): Blood pressure
Study 1685651 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1685651 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 1685651 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 1685651 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 26435363 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 21862727 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 21862727 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 7028259 — Predictive Biomarker (PRD): CAMP mRNA
Genes: CAMP; CAP18; FALL39; HSD26
Study 18455841 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18455841 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 18455841 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 29311135 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 29311135 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29311135 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study 20402570 — Predictive Biomarker (PRD): SIT1 mRNA
Genes: SIT1; SIT
Study 18326617 — Surrogate Endpoint (SUR): Bone mineral density
Study 23748948 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 21880194 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 21880194 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 15161831 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 7914121 — Surrogate Endpoint (SUR): Blood pressure
Study 25553889 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 15767053 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 12212928 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9866186 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8564344 — Surrogate Endpoint (SUR): Blood pressure
Study 2652168 — Surrogate Endpoint (SUR): Blood pressure
Study 25737192 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 23643256 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 22167437 — Surrogate Endpoint (SUR): Blood pressure
Study 15320685 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 8034236 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 2831127 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30279504 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30279504 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 27163694 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24508445 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18521047 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 31913150 — Surrogate Endpoint (SUR): Blood pressure
Study 25862439 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25862439 — Predictive Biomarker (PRD): Hormone receptor
Study 8911828 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 8911828 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8911828 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26684150 — Surrogate Endpoint (SUR): Serum calcium
Study 26684150 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 31722332 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 27481207 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 24264126 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 11528488 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7956214 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 7956214 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 7956214 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT